Hematopoietic neoplastic diseases develop in C3H/He and C57BL/6 mice after benzene exposure: Strain differences in bone marrow tissue responses observed using microarrays

Chemico-Biological Interactions

Volumn 184, Issue 1-2, 2010, Pages 240-245

  Inoue, Tohru ^a   Hirabayashi, Yoko ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

Acute myeloid leukemia (AML); C3H He; C57BL 6; Global gene expression profiles; Hematopoietic neoplasms (HNPs); Trp53 deficient mice

Indexed keywords

BENZENE;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; C3H MOUSE; C57BL 6 MOUSE; CELL SPECIFICITY; CHEMICAL CARCINOGENESIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DNA REPAIR; GENE EXPRESSION PROFILING; GENOMIC INSTABILITY; LEUKEMOGENESIS; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; SERIAL ANALYSIS OF GENE EXPRESSION; SIGNAL TRANSDUCTION; STOCHASTIC MODEL; STRAIN DIFFERENCE; WILD TYPE;

ANIMALS; BENZENE; GENE DELETION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, LEUKEMIC; GENOMIC INSTABILITY; HEMATOLOGIC NEOPLASMS; LEUKEMIA, MYELOID, ACUTE; LYMPHOMA; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; TUMOR SUPPRESSOR PROTEIN P53;

MUS;

EID: 77950629980     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2009.12.005     Document Type: Article

References (43)

1. Yoon B.I., Hirabayashi Y., Kawasaki Y., Kodama Y., Kaneko T., Kanno J., Kim D.Y., Fujii-Kuriyama Y., Inoue T. Aryl hydrocarbon receptor mediates benzene-induced hematotoxicity. Toxicol. Sci. 2002, 70(1):150-156.
2. Hirabayashi Y., Yoon B.I., Li G.X., Kaneko T., Kanno J., Fujii-Kuriyama Y., Inoue T. AhR-mediated benzene-induced hematopoietic toxicities: differential toxicities between one from AhR in the hematopoietic stem cells for the bone marrow and the other from possible hepatic-AhR for the peripheral blood. Organohalogen Compd. 2008, 70:287-290.
3. Hirabayashi Y., Yoon B.I., Li G.X., Fujii-Kuriyama Y., Kaneko T., Kanno J., Inoue T. Benzene-induced hematopoietic toxicity transmitted by AhR in wild-type mouse and nullified by repopulation with AhR-deficient bone marrow cells: time after benzene treatment and recovery. Chemosphere 2008, 73(1 Suppl):S290-294.
4. Lan Q., Zhang L., Li G., Vermeulen R., Weinberg R.S., Dosemeci M., Rappaport S.M., Shen M., Alter B.P., Wu Y., Kopp W., Waidyanatha S., Rabkin C., Guo W., Chanock S., Hayes R.B., Linet M., Kim S., Yin S., Rothman N., Smith M.T. Hematotoxicity in workers exposed to low levels of benzene. Science 2004, 306(5702):1774-1776.
5. Benzene in Drinking-water, Background document for development of WHO Guidelines for Drinking-water Quality, WHO/SDE/WSH/03.04/24, 2003.
6. Aksoy M., Erdem S., DinCol G. Leukemia in shoe-workers exposed chronically to benzene. Blood 1974, 44(6):837-841.
7. Yin S.N., Li G.L., Tain F.D., Fu Z.I., Jin C., Chen Y.J., Luo S.J., Ye P.Z., Zhang J.Z., Wang G.C., et al. Leukaemia in benzene workers: a retrospective cohort study. Br. J. Ind. Med. 1987, 44(2):124-128.
8. Vigliani E.C., Forni A. Benzene and leukemia. Environ. Res. 1976, 11(1):122-127.
9. Seki M., Yoshida K., Nishimura M., Nemoto K. Radiation-induced myeloid leukemia in C3H/He mice and the effect of prednisolone acetate on leukemogenesis. Radiat. Res. 1991, 127(2):146-149.
10. Yoshida K., Nojima K., Seki M., Inoue T. Radiation-induced myeloid leukemia following splenectomy in C3H/He mice. J. Radiat. Res. 1996, 37:380.
11. Kawasaki Y., Hirabayashi Y., Kaneko T., Kanno J., Kodama Y., Matsushima Y., Ogawa Y., Saitoh M., Sekita K., Uchida O., Umemura T., Yoon B.I., Inoue T. Benzene-induced hematopoietic neoplasms including myeloid leukemia in Trp53-deficient C57BL/6 and C3H/He mice. Toxicol. Sci. 2009, 110(2):293-306.
12. Li G.X., Hirabayashi Y., Yoon B.I., Kawasaki Y., Tsuboi I., Kodama Y., Kurokawa Y., Yodoi J., Kanno J., Inoue T. Thioredoxin overexpression in mice, model of attenuation of oxidative stress, prevents benzene-induced hemato-lymphoid toxicity and thymic lymphoma. Exp. Hematol. 2006, 34(12):1687-1697.
13. Hirabayashi Y., Yoon B.I., Tsuboi I., Huo Y., Kodama Y., Kanno J., Ott T., Trosko J.E., Inoue T. Protective role of connexin 32 in steady-state hematopoiesis, regeneration state, and leukemogenesis. Exp. Biol. Med. (Maywood) 2007, 232(5):700-712.
14. Yoshida K., Hirabayashi Y., Wada S., Watanabe F., Watanabe K., Aizawa S., Inoue T. p53 (TRP53) deficiency-mediated antiapoptosis escape after 5 Gy X irradiation still induces stem cell leukemia in C3H/He mice: comparison between whole-body assay and bone marrow transplantation (BMT) assay. Radiat. Res. 2007, 167(6):703-710.
15. Hirabayashi Y., Yoshida K., Aizawa S., Kodama Y., Kanno J., Kurokawa Y., Yoshimura I., Inoue T. Evaluation of nonthreshold leukemogenic response to methyl nitrosourea in p53-deficient C3H/He mice. Toxicol. Appl. Pharmacol. 2003, 190(3):251-261.
16. Chan C.W., Lee Y.B., Uney J., Flynn A., Tobias J.H., Norman M. A novel member of the SAF (scaffold attachment factor)-box protein family inhibits gene expression and induces apoptosis. Biochem. J. 2007, 407(3):355-362.
17. Etienne A., Gelsi-Boyer V., Carbuccia N., Adelaide J., Barba G., La Starza R., Murati A., Eclache V., Birg F., Birnbaum D., Mozziconacci M.J., Mecucci C., Chaffanet M. Combined translocation with ZNF198-FGFR1 gene fusion and deletion of potential tumor suppressors in a myeloproliferative disorder. Cancer Genet. Cytogenet. 2007, 173(2):154-158.
18. Chen J., Yu L., Li D., Gao Q., Wang J., Huang X., Bi G., Wu H., Zhao S. Human CRYL1, a novel enzyme-crystallin overexpressed in liver and kidney and downregulated in 58% of liver cancer tissues from 60 Chinese patients, and four new homologs from other mammalians. Gene 2003, 302(1-2):103-113.
19. Roy D., Guida P., Zhou G., Echiburu-Chau C., Calaf G.M. Gene expression profiling of breast cells induced by X-rays and heavy ions. Int. J. Mol. Med. 2008, 21(5):627-636.
20. Frescas D., Guardavaccaro D., Kuchay S.M., Kato H., Poleshko A., Basrur V., Elenitoba-Johnson K.S., Katz R.A., Pagano M. KDM2A represses transcription of centromeric satellite repeats and maintains the heterochromatic state. Cell Cycle 2008, 7(22):3539-3547.
21. Garrett R.W., Gasiewicz T.A. The aryl hydrocarbon receptor agonist 2,3,7,8-tetrachlorodibenzo-p-dioxin alters the circadian rhythms, quiescence, and expression of clock genes in murine hematopoietic stem and progenitor cells. Mol. Pharmacol. 2006, 69(6):2076-2083.
22. Harper P.A., Riddick D.S., Okey A.B. Regulating the regulator: factors that control levels and activity of the aryl hydrocarbon receptor. Biochem. Pharmacol. 2006, 72(3):267-279.
23. Y. Hirabayashi, T. Inoue, Benzene-induced bone-marrow toxicity: A hematopoietic stem-cell-specific, aryl hydrocarbon receptor-mediated adverse effect, Chem Biol Interact (2009) In press (). doi:10.1016/j.cbi.2009.1012.1022.
24. Hirabayashi Y., Miyajima A., Yokota T., Arai K., Li G.X., Yoon B.I., Kaneko T., Kanno J., Inoue T. Effect of 2, 3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on B cell differentiation in mouse pre-B colonization model regulated by artificially introduced human IL-3 receptors. Organohalogen Compd. 2002, 53:359-362.
25. Cronkite E.P., Inoue T., Carsten A.L., Miller M.E., Bullis J.E., Drew R.T. Effects of benzene inhalation on murine pluripotent stem cells. J. Toxicol. Environ. Health 1982, 9(3):411-421.
26. Cronkite E.P., Bullis J., Inoue T., Drew R.T. Benzene inhalation produces leukemia in mice. Toxicol. Appl. Pharmacol. 1984, 75(2):358-361.
27. Snyder C.A., Goldstein B.D., Sellakumar A.R., Bromberg I., Laskin S., Albert R.E. The inhalation toxicology of benzene: incidence of hematopoietic neoplasms and hematotoxicity in ARK/J and C57BL/6J mice. Toxicol. Appl. Pharmacol. 1980, 54(2):323-331.
28. French J.E., Lacks G.D., Trempus C., Dunnick J.K., Foley J., Mahler J., Tice R.R., Tennant R.W. Loss of heterozygosity frequency at the Trp53 locus in p53-deficient (+/-) mouse tumors is carcinogen-and tissue-dependent. Carcinogenesis 2001, 22(1):99-106.
29. NTP Toxicology and carcinogenesis studies of benzene (CAS No. 71-43-2) in F344/N rats and B6C3F1 mice (Gavage Studies), Natl. Toxicol. Program Tech. Rep. Ser., 1986, pp. 1-277.
30. Xiao A., Li H., Shechter D., Ahn S.H., Fabrizio L.A., Erdjument-Bromage H., Ishibe-Murakami S., Wang B., Tempst P., Hofmann K., Patel D.J., Elledge S.J., Allis C.D. WSTF regulates the H2A.X DNA damage response via a novel tyrosine kinase activity. Nature 2009, 457(7225):57-62.
31. Chung S., Zhou Z., Huddleston K.A., Harrison D.A., Reed R., Coleman T.A., Rymond B.C. Crooked neck is a component of the human spliceosome and implicated in the splicing process. Biochim. Biophys. Acta 2002, 1576(3):287-297.
32. Bakowska J.C., Jenkins R., Pendleton J., Blackstone C. The Troyer syndrome (SPG20) protein spartin interacts with Eps15. Biochem. Biophys. Res. Commun. 2005, 334(4):1042-1048.
33. Hanada K., Budzowska M., Modesti M., Maas A., Wyman C., Essers J., Kanaar R. The structure-specific endonuclease Mus81-Eme1 promotes conversion of interstrand DNA crosslinks into double-strands breaks. EMBO J. 2006, 25(20):4921-4932.
34. Fiume R., Ramazzotti G., Teti G., Chiarini F., Faenza I., Mazzotti G., Billi A.M., Cocco L. Involvement of nuclear PLCbeta1 in lamin B1 phosphorylation and G2/M cell cycle progression. FASEB J. 2009, 23(3):957-966.
35. Polyak K., Lee M.H., Erdjument-Bromage H., Koff A., Roberts J.M., Tempst P., Massague J. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 1994, 78(1):59-66.
36. Payne S.R., Kemp C.J. p27(Kip1) (Cdkn1b)-deficient mice are susceptible to chemical carcinogenesis and may be a useful model for carcinogen screening. Toxicol. Pathol. 2003, 31(4):355-363.
37. Nakayama K., Ishida N., Shirane M., Inomata A., Inoue T., Shishido N., Horii I., Loh D.Y. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 1996, 85(5):707-720.
38. Schar P., Fasi M., Jessberger R. SMC1 coordinates DNA double-strand break repair pathways. Nucleic Acids Res. 2004, 32(13):3921-3929.
39. Ikebuchi K., Chano T., Ochi Y., Tameno H., Shimada T., Hisa Y., Okabe H. RB1CC1 activates the promoter and expression of RB1 in human cancer. Int. J. Cancer 2009, 125(4):861-867.
40. Choi S.A., Kim S.J., Chung K.C. Huntingtin-interacting protein 1-mediated neuronal cell death occurs through intrinsic apoptotic pathways and mitochondrial alterations. FEBS Lett. 2006, 580(22):5275-5282.
41. Hackam A.S., Yassa A.S., Singaraja R., Metzler M., Gutekunst C.A., Gan L., Warby S., Wellington C.L., Vaillancourt J., Chen N., Gervais F.G., Raymond L., Nicholson D.W., Hayden M.R. Huntingtin interacting protein 1 induces apoptosis via a novel caspase-dependent death effector domain. J. Biol. Chem. 2000, 275(52):41299-41308.
42. Hirabayashi Y., Tsuboi I., Kitada K., Igarashi K., Kodama Y., Kanno J., Yoshida K., Dainiak N., Inoue T. Comparison of murine gene expression profiles between spontaneous and radiation-induced myelogenous leukemias: Stochastic and probabilistic expression variances in the former vs radiation-specific expression commonalities in the latter. Exp. Hematol. 2009, 37(2):195-205.
43. Hirabayashi Y., Inoue T. Principles of data-mining in toxicogenomics. Toxicogenomics: A Powerful Tool for Toxicity Assessment 2008, 57-84. John Wiley & Sons, Ltd., Hoboken, NJ. S.C. Sahu (Ed.).